Ken-ichi  Hanada, M.D., Ph.D.
Ken-ichi Hanada, M.D., Ph.D.
Staff Scientist

Center for Cancer Research
National Cancer Institute

Building 10, Room 3w-3840
Bethesda, MD 20892-1201
301-435-6190

Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.

Areas of Expertise
renal cell carcinoma
Selected Publications
  1. Gros A, Robbins PF, Yao X, Li YF, Turcotte S, Tran E, Wunderlich JR, Mixon A, Farid S, Dudley ME, Hanada K, Almeida JR, Darko S, Douek DC, Yang JC, Rosenberg SA.
    J. Clin. Invest.. [Epub ahead of print], 2014. [ Journal Article ]
  2. Hanada K, Restifo NP.
    Nat. Biotechnol.. 31: 33-4, 2013. [ Journal Article ]
  3. Abate-Daga D, Hanada K, Davis JL, Yang JC, Rosenberg SA, Morgan RA.
    Blood. 122: 1399-410, 2013. [ Journal Article ]
  4. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A.
    Immunity. 36: 79-91, 2012. [ Journal Article ]
  5. Wang QJ, Hanada K, Robbins PF, Li YF, Yang JC.
    Cancer Res.. 72: 6119-29, 2012. [ Journal Article ]

Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.

Summary

Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.

Areas of Expertise
renal cell carcinoma

Publications

Selected Publications
  1. Gros A, Robbins PF, Yao X, Li YF, Turcotte S, Tran E, Wunderlich JR, Mixon A, Farid S, Dudley ME, Hanada K, Almeida JR, Darko S, Douek DC, Yang JC, Rosenberg SA.
    J. Clin. Invest.. [Epub ahead of print], 2014. [ Journal Article ]
  2. Hanada K, Restifo NP.
    Nat. Biotechnol.. 31: 33-4, 2013. [ Journal Article ]
  3. Abate-Daga D, Hanada K, Davis JL, Yang JC, Rosenberg SA, Morgan RA.
    Blood. 122: 1399-410, 2013. [ Journal Article ]
  4. Tikhonova AN, Van Laethem F, Hanada K, Lu J, Pobezinsky LA, Hong C, Guinter TI, Jeurling SK, Bernhardt G, Park JH, Yang JC, Sun PD, Singer A.
    Immunity. 36: 79-91, 2012. [ Journal Article ]
  5. Wang QJ, Hanada K, Robbins PF, Li YF, Yang JC.
    Cancer Res.. 72: 6119-29, 2012. [ Journal Article ]

Biography

Dr. Hanada received M.D. degree at Tokyo Medical and Dental University and a Ph.D. at the University of Tokyo, Japan. He joined the Surgery Branch, NCI in 1997 as a visiting scientist and became a staff scientist in 2005. He has been involved in the basic studies of immune response to renal cell carcinoma and also in the development of clinical trials for renal cell carcinoma.